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Objectives. To evaluate a Danish translation of the Quick Environmental Exposure and Sensitivity Inventory (QEESI). Methods.
The study included two groups: one comprised a random sample of 2000 individuals drawn from the Danish Civil Registration
System; the other comprised 315 patients with chemical intolerance. Results. The evaluation suggested good reliability for the four
QEESI scales in terms of internal consistency and coeﬃcients between test and retest scores. The discriminatory validity was the
largest for the Chemical (inhalant) Intolerance and Life Impact Scales. Using combined cut-oﬀ scores for these two scales provided
a sensitivity of 92.1 and a speciﬁcity of 91.8 and yielded a prevalence of 8.2% in the population group. Conclusions. The Danish
translation of the QEESI showed overall good reliability and validity. We recommend the use of the combined Chemical (inhalant)
Intolerance and Life Impact Scales in future studies.
1.Introduction
Chemical intolerance, also referred to as multiple chemical
sensitivities (MCS), is a disorder characterized by reports of
nonspeciﬁcsymptomsfromvariousorgansystemsattributed
by the individual to exposure to common airborne chem-
icals [1]. In general the reported symptoms are attributed
to previous chemical exposures and recur on subsequent
exposures to the same or structurally unrelated chemicals at
levels normally considered to be nontoxic [1].
Symptoms of chemical intolerance are prevalent with
estimates ranging from 9 to 33% in population-based stud-
ies; however, such studies are few [2–7]. Physician-diagnosed
MCS or reports of disabling consequences in the form of
social and occupational disruptions attributed to exposure
to common airborne chemicals range from 0.5 to 6.3%
[2–4, 7]. The reported symptoms typically vary between
individuals with women being more sensitive and reporting
more symptoms than do men [2, 5–7]. A typical symptom
p a t t e r ni st h u sd i ﬃcult to establish. Nonspeciﬁc central
nervous system (CNS) complaints are frequently reported,
including fatigue, headache, and diﬃculty concentrating
[2, 8, 9]. Other symptoms include pain and respiratory
complaints [2, 5, 6]. An association between asthma and
chemical intolerance has been reported in several studies [2,
10, 11]. In a population-based twin study on the heritability
of perfume-related respiratory symptoms, Elberling and
colleagues reported a heritability of 0.35 [12]. A mutual
genetic correlation of 0.39 was reported for perfume-related
respiratory symptoms and atopic dermatitis, suggesting
some genetic pleiotropy for these two factors. No genetic
pleiotropy was found between perfume-related respiratory
symptoms, hand eczema, contact allergy, or asthma [12],
suggesting that the association with asthma might be caused
by mechanisms other than genetic susceptibility. Increasing
evidence points to an association between MCS and symp-
toms of psychological distress, that is, depressive symptoms,
somatisation, negative aﬀect, and anxiety [13–18], which are
likely to add to the level of overall functional disability.
The label “MCS” was initially proposed by Cullen based
onclinicalobservations[19].Althoughmorecasedeﬁnitions
have been proposed since the introduction of Cullen’s2 Journal of Environmental and Public Health
criteria in 1987 [9, 20], none is currently widely accepted
[20, 21]. The absence of widely accepted case criteria for
establishing the presence and degree of chemical intolerance
challenges epidemiological and clinical studies in this ﬁeld.
Several self-report questionnaires have been developed for
researchpurposes[22–24].Thequestionnairethatappearsto
have been most widely applied is the Quick Environmental
Exposure and Sensitivity Inventory (QEESI) developed by
Miller and Prihoda [25, 26]. QEESI is a reliable and
valid self-administered questionnaire that was developed to
gauge the multisystem symptoms and multiple intolerances
often reported in chemical intolerance [25, 26]. QEESI
consists of ﬁve scales measuring diﬀerent domains related to
chemical intolerance, that is, commonly reported symptoms,
chemical (inhalant) intolerances, other intolerances (e.g.,
allergies, foods, alcohol), life impact attributed to chemical
intolerances, and on-going exposures from routinely used
products (Masking Index). Four of the QEESI scales consist
of ten items where responses are rated on an eleven point
scale ranging from “not at all a problem” (0) to “disabling
symptoms” [10], resulting in a score range from 0 to 100.
The ﬁfth, the Masking Index, also consists of ten items,
but the response format is dichotomous (0 or 1), resulting
in a score range from 0 to 10. QEESI has been translated
into a number of diﬀerent languages, that is, Swedish [27],
Japanese [28, 29], and Spanish [30], of which the Swedish
and Japanese versions have also been evaluated in terms of
validity and reliability. The Swedish study included a mildly
(n = 67) and a moderately/severely chemically intolerant
group (n = 126) and a control group (n = 90). The
study concluded that the Swedish version of QEESI is reliable
and valid for investigating chemical intolerance [27]. The
Japanese study included a general population group (n =
498) and an outpatient group with self-reported MCS (n =
131) [28]. Based on principal components analyses, this
study concluded that three of the QEESI subscales, that is,
Symptom Severity, Chemical (inhalant) Intolerances, and
Life Impact, were valid. To the best of our knowledge, no
other study has established normative data based on a large
population-based sample, and an evaluation of a Danish
version of QEESI will not only strengthen future studies
on chemical intolerance but will also enable international
comparisons of data.
T h eo b j e c t i v e so ft h ep r e s e n ts t u d yw e r e( 1 )t oe v a l u a t e
a Danish translation of the QEESI in relation to validity
and reliability, (2) to describe sensitivity and speciﬁcity, (3)
to test whether asthma and high scores (based on Danish
population norms) on SCL-92 subscales of depression and
somatisation were associated with scores on QEESI, and (4)
to establish normative data.
2. Methods
2.1. Participants. Two groups were invited to participate
in the study: (1) individuals from the general population
and (2) individuals who had contacted the Danish Research
C e n tr eb e c a u s eo fs ym p t o m sa t tri b u t e dt oc o m m o na i rb o rn e
chemicals, and patients with physician-diagnosed chemical
intolerance.
2.1.1. General Population. A random sample of 18–69-year-
old (n = 2000) from the general population was drawn from
the Danish Civil Registration system in January 2010.
2.1.2. Patients. The patient sample (n = 315) comprised
individuals who had contacted the Danish Research Centre
for Chemical Sensitivities between January 1, 2006 and
January 1, 2010 (n = 183) because of reactions consistent
with chemical intolerance, and individuals who had received
a diagnosis of chemical intolerance either at the Copenhagen
University Hospital, Rigshospitalet, or at Hamlet, Private
Hospital, Denmark, between January 1, 1990 and January 1,
2009 (n = 132) by the same ear-nose-and throat specialist.
2.2. Measurements
2.2.1. A Danish Translation of QEESI. The original version of
QEESI [25, 26] was translated into Danish by a professional
translation agency. The Danish translation was subsequently
tailored to Danish usage and then translated back to the
original language by a diﬀerent professional translator. The
backtranslationwasthencomparedwiththeoriginalversion
of QEESI to identify potential sense-altering discrepancies.
Finally, the Danish translation was pilot tested among
individuals with chemical intolerance for comprehension
and ease of completion.
2.2.2. Symptom Checklist 92. Symptom Checklist 92 (SCL-
92) subscales for depression and somatisation were included.
These subscales comprise 25 items where responses are rated
on a 5-point Likert scale ranging from not at all to very
much. The SCL-92 has been validated in a general Danish
population and normative data have been established [31,
32].
2.2.3. Asthma. Questions on asthma were adopted from
the Stage 1 questionnaire of the European Community
Respiratory Health Study (ECRHS) [33]. Asthma was
deﬁned according to criteria employed by the ECRHS as an
aﬃrmative answer to at least one of the following questions:
(1) Have you been woken by an attack of shortness of breath at
any time in the last 12 months? (2) Have you had an attack of
asthma in the last 12 months? (3) Are you currently taking any
medicine (including inhalers, aerosols, or tablets) for asthma?
[34].
2.2.4. Procedure. A questionnaire was sent to the partici-
pants on two occasions. The ﬁrst test occasion included
(1) the QEESI, (2) questions on socioeconomic position,
categorizedinaccordancewiththeBritishRegistrarGeneral’s
Classiﬁcation I–V [35], (3) the SCL-92 somatisation and
depression subscales, and (4) the ECRHS asthma questions.
Demographic data, for example, age and sex, were available.
Two months after responding to the ﬁrst questionnaire,
a random sample of the respondents from the generalJournal of Environmental and Public Health 3
population (n = 200) and 140 patients who had responded
to the ﬁrst questionnaire received a second questionnaire,
which consisted of the QEESI only. The overall response rate
to the ﬁrst questionnaire was 64.5%. The response rates in
the population sample were 65.3% (n = 1305/2000) on the
ﬁrst test occasion and 61.0% (n = 122/200) on the second
test occasion. The response rates in the patient sample were
60.0% (n = 189/315) on the ﬁrst test occasion and 80.0%
(n = 112/140) on the second test occasion.
3.StatisticalAnalysis
3.1. Reliability and Validity. The internal consistency of
the four QEESI scales (Chemical (inhalant) Intolerances,
Symptom Severity, Other Intolerances, and Life Impact) was
evaluated using Cronbach’s alpha [36]. Coeﬃcients were cal-
culated for the patient sample and for age stratiﬁed samples
of the population. Test-retest reliability was evaluated using
Pearson correlations.
The discriminatory validity of the QEESI was evaluated
using bivariate logistic regression, and multivariate analyses
were also used for the Chemical (inhalant) Intolerance and
Life Impact Scales. Criterion validity was addressed using the
variables asthma, somatisation, and depression, for which
associations with chemical intolerance have been reported.
These variables were dichotomized using the ECRHS asthma
criteria and the gender-based cut-oﬀ scores for the SCL-
92 somatisation and depression subscales described by
Olsen and colleagues [31, 32]. Further, cross-validation was
performed by randomly dividing the data set in two and
comparing results with those obtained for the entire data set.
3.2. Diﬀerential Item Functioning. Diﬀerential item func-
tioning (DIF) is the phenomenon that performance of items
diﬀe r sa c r o s ss u b p o p u l a t i o n so rt h a ti t e m sm e a s u r ed i ﬀerent
things for members of one subpopulation as opposed to
members of another. Instruments containing such items
may have reduced validity for between-group comparisons
because scores may be indicative of attributes other than
those the instrument is intended to measure [37]. We tested
DIF by testing conditional independence given the total
score. We used the partial gamma coeﬃcient [38], suggested
by Kreiner when items are polytomous [39]. DIF with
respect to asthma was tested using the ECRHS criteria, and
depressive and somatising individuals were identiﬁed using
the SCL-92 cut-oﬀ scores [31, 32].
DatawereanalysedusingSPSS,version15.0forWindows
and SAS version 9.2.
4.Approval
T h es t u d yw a sa p p r o v e db yt h eD a n i s hD a t aP r o t e c t i o n
Agency. According to Danish legislation questionnaire stud-
ies do not need approval from an ethics committee.
5. Results
5.1. Sample Characteristics. Characteristics of the patient-
and population samples are shown in Table 1.D u et os k e w e d
distributions, the medians for the ﬁve QEESI scales (the
Symptom Severity, Chemical (inhalant) Intolerances, Other
Intolerances, Life Impact Scales, and the Masking Index) are
presented. Table 1 also includes sex and age distributions
for the two samples, mean and median scores on the
two SCL-92 subscales, as well as occupational social class
(SES). Table 1 shows that scores on the QEESI and SCL-
92 diﬀered signiﬁcantly in the expected direction between
the two samples. In analyses stratiﬁed by gender QEESI
scores also diﬀered signiﬁcantly (P<0.0001) between the
two groups (data not shown). In terms of QEESI, scores
also diﬀered signiﬁcantly (P<0.0001) between women in
the population and patient samples as well as between men
(data not shown). In regards to age, the patient sample was
signiﬁcantly older than the population and diﬀerences were
also seen in relation to SES classiﬁcations, which may be a
consequence of the diﬀerences seen in age.
5.2. Reliability. Cronbach alpha coeﬃcients and median
scores on the four QEESI scales (Chemical (inhalant)
Intolerances, Symptom Severity, Other Intolerances, and
Life Impact) are shown in Table 2. The Cronbach alpha
coeﬃcients were overall high in both groups (range 0.64–
0.94) for all four scales suggesting good internal consistency
(Table 2).
Pearson correlation analyses of test-retest reliability
showed statistically signiﬁcant coeﬃcients for the ﬁve scales:
the Chemical (inhalant) Intolerances Scale (0.94, n = 230),
the Symptom Severity Scale (0.89, n = 234), the Other
Intolerances Scale (0.89, n = 233), the Life Impact Scale
(0.96, n = 232), and the Masking Index (0.84, n = 234).
5.3. Validity. The discriminatory validity of the ﬁve QEESI
scales is shown in Table 3. In the simple logistic regression
analyses, the discriminatory power was the largest for the
Chemical (inhalant) Intolerance and the Life Impact Scale,
and these two scales were therefore selected for subsequent
multivariate analyses. Calculating other pairwise compar-
isons resulted in lower values than the one speciﬁed for the
Chemical (inhalant) Intolerance and the Life Impact Scales
(data not shown). Including more scales in the analysis did
not substantially change the result since the maximum value
obtained for all ﬁve scales was 0.98 (data not shown).
To test whether other variables found to be associated
with chemical intolerance, that is, asthma, somatisation, and
depression, would inﬂuence the discriminatory validity of
the Chemical (inhalant) Intolerance and the Life Impact
Scales, other subsequent statistical analyses were performed.
Area under the ROC curve was calculated using the ECRHS
asthma criteria and the gender-based cut-oﬀ scores for the
SCL-92 somatisation and depression subscales, as described
by Olsen and colleagues [31, 32], in the analyses. The
following results were obtained: for the Chemical (inhalant)
Intolerance Scale the area under the ROC curve for asthma4 Journal of Environmental and Public Health
Table 1: Characteristics of the patient and the population samples.
Population sample Patient sample
P-value1
Men Women Total Men Women Total
600 705 1305 25 163 188
Age, mean (sd) 47.4 (14.1) 46.8 (14.3) 47.1 (14.2) 52.4 (14.7) 56.0 (10.8) 55.5 (11.5) <0.0001
QEESI (median) P-value2
Symptoms 9.0 14.0 11.0 35.0 48.0 47.0 <0.0001
Chemical Int. 11.0 15.0 13.0 81.6 82.2 82.1 <0.0001
Other Int. 6.0 12.0 10.0 27.3 35.5 35.0 <0.0001
Life Impact 0.0 3.0 2.0 70.0 64.0 65.0 <0.0001
Masking Index 4.0 4.0 4.0 2.0 2.0 2.0 <0.0001
SCL-92 (median)
Depression 0.15 0.31 0.23 0.62 0.69 0.69 <0.0001
Somatisation 0.25 0.33 0.33 0.83 1.0 1.0 <0.0001
SCL-92 (mean)
Depression 0.39 0.53 0.47 1.0 0.86 0.88 —
Somatisation 0.38 0.51 0.45 1.0 1.13 1.12 —
Occupational social class (n (%)) P-value3
<0.0001
I + II: 224 (17.2) 17 (9.0)
III + IV: 426 (32.6) 35 (18.5)
V + VI + VII: 566 (43.4) 124 (65.6)
Missing: 89 (6.8) 13 (6.9)
Occupational social class: I + II: professionals and executives and medium-level white-collar employees; III + IV: low-level white-collar employees and skilled
workers; V + VI + VII: unskilled and semiskilled workers, individuals receiving pension or disability beneﬁts, and students.
1Independent samples t-test for equality of means (total) between population and patient samples.
2Mann-Whitney test (total) comparing population and patient samples.
3Chi-squared test comparing population and patient samples.
Table 2: Median scores and scale reliability coeﬃcients (Cronbach’s alpha).
Scale group N Symptom scale Chemical intolerance scale Other intolerance scale Life Impact scale
Median (IQR)∗∗ Alpha∗∗∗ Median (IQR) Alpha Median (IQR) Alpha Median (IQR) Alpha
Patient sample 189 47 (30–64) 0.84 80 (62–91) 0.91 34 (20–53) 0.83 64 (45–80) 0.89
Population 1309 11 (5–23) 0.86 13 (4–30) 0.92 10 (3–19) 0.77 2 (0–8) 0.86
Population∗
−30 201 12 (5–23) 0.83 11 (4–24) 0.87 11 (3–19) 0.64 4 (0–10) 0.74
30–40 218 11 (4–21) 0.85 15 (5–31) 0.93 11 (5–22) 0.79 2 (0–8) 0.86
40–50 288 11 (6–22) 0.89 14 (5–30) 0.92 11 (5–18) 0.79 2 (0–8) 0.90
50–60 312 12 (5–23) 0.86 14 (4–32) 0.94 8 (3–17) 0.78 1 (0–9) 0.87
60− 290 10 (4–23) 0.86 12 (1–29) 0.93 5 (0–17) 0.75 0 (0–5) 0.81
∗Population sample grouped by age.
∗∗Interquartile range.
∗∗∗Cronbach’s alpha.
was 0.93 (95%CI0.90–0.95), for somatisation 0.89 (95%CI
0.86–0.94) (women) and 0.91 (95%CI 0.88–0.94) (men),
and for depression 0.94 (95%CI 0.91–0.97) (women) and
0.94 (95%CI 0.91–0.96) (men); for the Life Impact Scale the
areaundertheROCcurveforasthmawas0.94(95%CI0.91–
0.96), for somatisation 0.88 (95%CI 0.84–0.93) (women)
and 0.91 (95%CI 0.88–0.94) (men), and for depression
0.92 (95%CI 0.88–0.95) (women) and 0.93 (95%CI 0.89–
0.95) (men) (data not shown). These results suggest that
the area under the ROC curve is slightly lowered with
coexisting asthma, depression, or somatisation; nevertheless
the discriminatory validity of QEESI is still good. Randomly
dividing the data set in two yielded results that corresponded
with the results obtained for the entire data set: ChemicalJournal of Environmental and Public Health 5
Table 3: Discriminatory power of the ﬁve QEESI scales either when used alone (univariate analyses) or when combined in a multivariate
logistic regression model.
Scale univariate P-value Odds ratio (95% CI) one-point increase Area under ROC curve
Symptom severity <0.0001 1.07 (1.06–1.08) 0.88 (0.85–0.90)
Chemical intolerances <0.0001 1.11 (1.09–1.12) 0.97 (0.95–0.98)
Other Intolerances <0.0001 1.07 (1.06–1.08) 0.84 (0.81–0.87)
Life Impact <0.0001 1.10 (1.09–1.12) 0.97 (0.96–0.98)
Masking Index (rev)∗ <0.0001 2.48 (2.16–2.06) 0.81 (0.78–0.84)
Multivariate
Chemical intolerances <0.0001 1.06 (1.05–1.08) 0.98
Life Impact <0.0001 1.06 (1.05–1.07)
∗Scores on the Masking Index were reversed in the statistical analyses.
Table 4: Diﬀerential item functioning (DIF). Only signiﬁcant results are shown.
Scale Item Asthmatics Depressives Somatisers
partial γ coeﬃcient
Chemical int.
item 2 (tobacco smoke) 0.17 (se = 0.06) −0.16 (se = 0.06) —
item 4 (gasoline) −0.23 (se = 0.06) — —
item 8 (tar) — 0.16 (se = 0.04) −0.17 (se = 0.06)
Life Impact
item 2 (work ability) — 0.14 (se = 0.06) —
item 4 (choice of clothing) — −0.31 (se = 0.12) —
item 6 (choice of products) −0.16 (se = 0.08) — —
item 8 (choice of hobbies) 0.20 (se = 0.09) — —
item 9 (relation with spouse) — — −0.19 (se = 0.10)
Symptom severity
item 1 (muscle and joint pain) 0.23 (se = 0.06) −0.19 (se = 0.06) —
item 2 (mucosal or respiratory) 0.47 (se = 0.04) −0.30 (se = 0.07) —
item 4 (stomach and digestive) — −0.17 (se = 0.07) —
item 5 (concentration/memory) −0.16 (se = 0.06) 0.36 (se = 0.06) —
item 6 (tension and nervousness) −0.15 (se = 0.07) 0.79 (se = 0.04) —
item 7 (balance or coordination) — 0.21 (se = 0.07) 0.24 (se = 0.08)
item 10 (genital and urinary) −0.20 (se = 0.06) — −0.27 (se = 0.08)
Other Int.
item 3 (unusual cravings) −0.33 (se = 0.06) — —
item 4 (feeling ill after meals) — 0.42 (se = 0.08) 0.39 (se = 0.07)
item 6 (feeling ill) −0.21 (se = 0.08) 0.24 (se = 0.09) —
item 7 (alcoholic drinks) — 0.27 (se = 0.09) —
item 10 (allergic reactions) 0.36 (se = 0.06) −0.21 (se = 0.10) —
Masking Index
item 2 (alcoholic intake) −0.17 (se = 0.08) −0.54 (se = 0.09) —
item 4 (fragranced products) −0.51 (se = 0.06) −0.35 (se = 0.11) —
item 10 (routine use of medicine) 0.62 (se = 0.05). 0.72 (se = 0.06) —
(inhalant) Intolerance Scale (OR 1.07, 95%CI 1.05–1.09)
and the Life Impact Scale (OR 1.05, 95%CI 1.03–1.07) (Area
under the ROC curve 0.98).
Construct validity was tested by analysing diﬀerential
item functioning (DIF), which investigates if item scores are
aﬀected by external variables. DIF was tested in asthmatics
and in depressives and somatisers using the SCL-92 cut-
oﬀ scores for caseness [31, 32]. Only statistically signiﬁcant
results are presented in Table 4.
5.4. Sensitivity and Speciﬁcity. Figure 1 shows the distribu-
tion of scores in the two groups and cut-oﬀ values for all
four scales. Using all scales provided a sensitivity of 92.1%
and a speciﬁcity of 93.1%. The ROC curves for the Chemical
(inhalant) Intolerance and Life Impact Scales are shown in
Figure 2.The95%sensitivityandspeciﬁcityandoptimalcut-
oﬀ scores for the Chemical (inhalant) Intolerance and the
Life Impact Scales when used separately or when combined
are shown in Table 5. When used separately, the cut-oﬀ6 Journal of Environmental and Public Health
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Figure 1: Distribution of the two study samples responses to the four QEESI scales.Journal of Environmental and Public Health 7
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Figure 2: ROC curves for the Chemical (inhalant) Intolerance and
Life Impact Scales.
values that provided the highest sensitivity and speciﬁcity
for the two scales were 47 and 21 respectively (Table 5).
Combining the two scale scores by using cut-oﬀso f3 5
(Chemical Intolerance scale) and 14 (Life Impact Scale)
provided highest sensitivity and a speciﬁcity (Table 5). Miller
and Prihoda [25, 26] used logistic regression to estimate a
weighted sum of QEESI scales and an interaction term (the
product of two scales) that could be used to provide an
optimal cut-point. We used logistic regression ﬁnding no
signiﬁcant interactions. In our data this weighted approach
yields a sensitivity of 94% and speciﬁcity of 91% by ﬁrst
computing R =− 3.9665 + 0.0619
∗ chemicalintolerance −
0.0342∗ otherintolerance+0.6104∗ maskingindex+0.0767∗
lifeimpactscale − 0.00242∗ symptoms and then computing
the predicted probability prpr = exp(R)/(1 + exp(R)) and
Table 5: Sensitivity, speciﬁcity, and optimal cut-oﬀ values for the
chemical intolerance scale and the Life Impact Scale.
Chemical intolerance cut-oﬀ
scores Sensitivity (%) Speciﬁcity (%)
37 95.2 82.8
47 89.3 89.4
58 83.9 95.2
Life Impact Scale cut-oﬀ
scores Sensitivity Speciﬁcity
14 95.8 86.2
21 91.0 90.9
31 86.8 95.2
Combined scale scores Sensitivity Speciﬁcity
Chemical intolerance cut-oﬀ
35/Life Impact Scale cut-oﬀ
14
92.1 91.8
classifying a subject as “chemically sensitive” if prpr > 0.09.
These analyses suggest that the diﬀerence between our
approach and Miller and Prihoda’s is minimal.
6. Discussion
The evaluation of the Danish version of QEESI suggested
good reliability for the four scales, that is, Chemical
(inhalant) Intolerances, Life Impact, Symptom Severity, and
Other Intolerances, in terms of internal consistency and
coeﬃcients between test and retest scores.
The overall response rate to the ﬁrst questionnaire was
64.5%. For the sample characteristics, the patients were
signiﬁcantly older than the general population sample and
diﬀerenceswerealsofoundinrelationtoSES,whichmaybea
consequenceoftheagediﬀerences.Inaccordancewithresults
reported in other studies, the patient group also scored
signiﬁcantly higher on the SCL-92 subscales [18, 40]. Scores
on the QEESI diﬀered between the samples in the expected
direction as the patients scored signiﬁcantly higher on all
four scales, that is, the Chemical (Inhalant) Intolerances, Life
Impact, Symptom Severity and Other Intolerances Scales,
whereas the population scored signiﬁcantly higher on the
Masking Index.
Our results on the Cronbach alpha coeﬃcients for all
four scales and test-retest reliability showed good internal
consistency and reliability and correspond to the results
obtained in other studies evaluating the QEESI. The Cron-
bach alphas obtained in this study ranged from 0.64 to 0.94
in the population sample with a tendency to lower scores
in the youngest age group, whereas the range in the patient
sample was 0.83 to 0.91. Miller and Prihoda reported a
corresponding range of 0.89–0.97 for the original American
version of the questionnaire [25, 26]. Evaluating a Swedish
version of the QEESI, Nordin and Andersson reported a
range of 0.74 to 0.95 [27], and in the Japanese version
the range was 0.87 to 0.94 for the Chemical (inhalant)
Intolerances, the Life Impact, and the Symptom Severity
scales [28].8 Journal of Environmental and Public Health
Thediscriminatory validity wasthelargestfortheChem-
ical (inhalant) Intolerance and Life Impact Scales. Testing
the inﬂuence of other variables, that is, asthma, depression,
and somatisation, by calculating area under the ROC curve
did not substantially change the results. Using combined
cut-oﬀ scores of 35 for the Chemical (inhalant) Intolerance
Scale and 14 for the Life Impact Scale provided the best
simultaneoussensitivityandspeciﬁcity,thatis,92.1and91.8,
respectively. The corresponding sensitivity and speciﬁcity
for all ﬁve QEESI scales were 92.1% and 93.1%. Miller
and Prihoda found that the discriminatory power for the
Symptom Severity and the Chemical (inhalant) Intolerance
Scales was largest [26]. They reported a sensitivity of 83.2%
and a speciﬁcity of 84.2% using a cut-oﬀ score of ≥40 for the
Chemical (inhalant) Intolerance Scale [26]. Using the cut-
oﬀscorescollectivelyfortheChemical(inhalant)Intolerance
Scale (≥40), the Symptom Severity Scale (≥40) and the
OtherIntoleranceScale(≥25)providedasensitivityof67.2%
and a speciﬁcity of 90.9% [26]. In the Japanese evaluation of
three of the QEESI scales, Hojo et al. reported the highest
discriminatory ability for the Symptom Severity Scale with a
cut-oﬀ score of ≥20, which provided a sensitivity of 84.8%
and a speciﬁcity of 84.0% [29]. Sensitivity and speciﬁcity for
the Life Impact Scale were 84.8% and 85.7%, respectively,
with a cut-oﬀ score of ≥10. Contrary to our ﬁndings and
the ﬁndings by Miller and Prihoda, the Japanese version
of the Chemical (inhalant) Intolerance Scale had a low
sensitivity(73.4%)andspeciﬁcity(69.6)usingacut-oﬀscore
of ≥40 [29]. The cut-oﬀ scores applied in the Japanese study
were deﬁned uniquely for the Japanese translation. Nordin
and Andersson reported good discriminatory power for the
SymptomSeverity,Chemical(inhalant)Intolerance,andLife
Impact Scales [27]. The diﬀerent ﬁndings may reﬂect cross-
cultural diﬀerences in the responses to QEESI or, perhaps
more likely, reﬂect diﬀerences in study populations in
relation to the selection and deﬁnition of cases. Nevertheless
when applying the QEESI in epidemiological studies or in
clinical research, our results suggest that using the combined
cut-oﬀs scores for the Chemical (inhalant) Intolerance and
the Life Impact Scales provides a shorter and equally strong
alternative.
Construct validity was tested by analysing diﬀerential
item function (DIF). Item function is supposed to be
invariant of other, and in this regard, irrelevant constructs
[41]. Our analyses suggested that scores on several items on
all ﬁve scales were inﬂuenced if the respondent had asthma
according to the ECRHS criteria or had scores above the
cut-oﬀ values for caseness on the SCL-92 subscales, which
may have a negative impact on the construct validity of
the Danish translation of QEESI. The use of the ECRHS
deﬁnition on asthma has been validated with bronchial
hyperresponsiveness to methacholine (BHR) [33]b u tn o t
validated among individuals with chemical intolerance and
mightthereforeoverestimateacorrelation.However,positive
correlations between asthma and chemical intolerance have
been described in studies using other self-reported asthma
deﬁnitions [7, 42]a sw e l la so b j e c t i v em e a s u r e m e n t so fB H R
[43].UsingthestandardsforinterpretationofDIFappliedby
Bjorner et al. [41], the magnitude of DIF for the three items
on the Chemical (inhalant) Intolerance Scale, that showed
indication of DIF, was none or negligible. The same applied
for the Life Impact Scale except for one item (choice of
clothing) in relation to depression, which was in the slight
to moderate range. However, taken together the magnitude
of DIF appears to be of little importance for the construct
validity of these two scales. For the remaining three scales
the sizes of the gamma coeﬃcients suggested that DIF may
be a problem. However, this study is the ﬁrst to test DIF
in relation to the QEESI. Therefore, we cannot compare
our results with others and thereby determine whether DIF
occurs in other translations of the questionnaire than the
Danish version. Accordingly, we recommend that future
studies on QEESI address this issue. Altogether our results
provide additional evidence of the reliability and validity
of QEESI as a clinical survey tool for MCS. The size of
the study and the response rate to the questionnaire on
both the ﬁrst and the second test occasion support the
validity of our results. However, like most questionnaire-
based studies, the information gathered relies upon self-
reported and retrospective data, which must be kept in mind
when interpreting the results. While reliability and validity
of the diﬀerent translations of QEESI have proven to be good
and thereby support the use of the questionnaire in future
studies, diﬀerences in the case deﬁnitions applied in the
studies still point to diﬃculties in the comparisons of results
across countries. As stated by Miller and Prihoda in their
study published in 1999, the lack of a uniform approach for
identifying individuals with chemical intolerance is a barrier
for progress in this area [26]. Thus more research in this
area is needed to establish internationally agreed diagnostic
criteria. Meanwhile, the QESSI provides a good research tool
with a response format that allows for continuous scores that
may also be used in the evaluation of the eﬀectiveness of
treatments.
In conclusion, the Danish translation of the QEESI
showed overall good reliability and validity, which is in
accordance with the results reported in other studies. Our
analyses of construct validity suggested that there may be
problems with DIF in three of the QEESI scales. As our study
is the ﬁrst to conduct these analyses, we cannot conclude
whether this applies only to the Danish translation. We
therefore recommend that future studies on QEESI address
this issue. For research purposes, we recommend use of
the combined Chemical (inhalant) Intolerance and the Life
ImpactScalesscores,whichprovidedasensitivity of92.1and
a speciﬁcity of 91.8 in this study.
Abbreviation List
MCS: Multiple chemical sensitivity
QEESI: Quick Environmental Exposure and
Sensitivity Inventory
SCL-92: Symptom Checklist 92.
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